Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 8 of 17 for:    LENALIDOMIDE AND Leukemia AND Azacitidine

Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01241786
Recruitment Status : Terminated (anticipated results not seen and population not seen)
First Posted : November 16, 2010
Last Update Posted : November 8, 2012
Celgene Corporation
Information provided by (Responsible Party):
Hackensack Meridian Health

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Terminated
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 May 21, 2013
July 9, 2013
2 July 17, 2013
(Canceled - Date Unknown)
July 30, 2013
August 30, 2013
3 September 3, 2013
(Canceled - Date Unknown)
September 12, 2013
(Canceled - Date Unknown)
September 13, 2013
(Canceled - Date Unknown)
September 13, 2013
(Canceled - Date Unknown)
September 20, 2013
November 21, 2013
4 November 25, 2013
(Canceled - Date Unknown)
December 3, 2013
(Canceled - Date Unknown)
December 20, 2013
(Canceled - Date Unknown)
February 28, 2014
April 11, 2014